CDK8/19-IN-51 is an orally active and highly effective dual inhibitor of CDK8 and CDK19, with anticancer activity. Its IC50 values for CDK8 and CDK19 are 5.1 nM and 5.6 nM, respectively. It is used in studies of colorectal and gastric cancers.
Molecular Weight:
414.46
Purity:
98.65%
CAS Number:
[1860885-61-5]
Formula:
C23H22N6O2
Target:
CDK
T22633
T22633
* VAT and and shipping costs not included. Errors and price changes excepted